Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
RESEARCH TOOLSreports
Holding ARQT?
Track your performance easily
Arcutis Biotherapeutics (ARQT) Ownership Overview
7.98% Insiders
17.57% Mutual Funds
0.99% Other Institutional Investors
14.97% ETFs
58.49% Public Companies and Individual Investors
The ownership structure of Arcutis Biotherapeutics (ARQT) stock is a mix of institutional, retail, and individual investors. Approximately 33.53% of the company’s stock is owned by Institutional Investors, 7.98% is owned by Insiders, and 58.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 03, 2024 | Larry Todd Edwards Svp Chief Commercial Officer | xxxxxxxxxxxxx | $37287 |
| Sep 25, 2024 | xxxxxxxxxxxxx | $110214 | |
| Aug 21, 2024 | Patrick Burnett Reporting Person's Title: Svp And Chief Medical Officer | xxxxxxxxxxxxx | $14308 |
| Jul 02, 2024 | Howard G. Welgus Director | xxxxxxxxxxxxx | $93100 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $61119 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $241800 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $615334 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $14494050 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,166,436 | Institution | 5.28% | 53,463,000 | |
| 4,867,706 | Insider | 5.20% | 42,203,011 | |
| 4,906,926 | Institution | 4.20% | 42,543,048 | |
| 4,511,886 | Institution | 3.86% | 39,118,052 | |
| 3,616,532 | Institution | 3.09% | 31,355,332 | |
| 3,205,790 | Institution | 2.74% | 27,794,199 | |
| 3,085,198 | Institution | 2.64% | 26,748,667 | |
| 2,735,010 | Institution | 2.34% | 23,712,537 | |
| 1,681,047 | Institution | 1.44% | 14,574,677 | |
| 1,558,500 | Institution | 1.33% | 13,512,195 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,511,886 | Institution | 3.86% | 39,118,052 | |
| 3,085,198 | Institution | 2.64% | 26,748,667 | |
| 2,735,010 | Institution | 2.34% | 23,712,537 | |
| 1,525,545 | Institution | 1.31% | 13,226,475 | |
| 1,173,874 | Institution | 1.00% | 10,177,488 | |
| 1,105,897 | Institution | 0.95% | 9,588,127 | |
| 1,072,979 | Institution | 0.92% | 9,302,728 | |
| 903,900 | Institution | 0.77% | 7,836,813 | |
| 538,084 | Institution | 0.46% | 4,665,188 | |
| 478,938 | Institution | 0.41% | 4,152,392 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,589,510 | Institution | 3.07% | 33,382,443 | |
| 3,052,907 | Institution | 2.61% | 25,369,657 | |
| 2,748,081 | Institution | 2.35% | 23,825,862 | |
| 1,605,716 | Institution | 1.37% | 14,933,159 | |
| 945,455 | Institution | 0.81% | 8,197,095 | |
| 714,680 | Institution | 0.61% | 6,196,276 | |
| 486,264 | Institution | 0.42% | 4,522,255 | |
| 504,888 | Institution | 0.43% | 4,195,619 | |
| 443,042 | Institution | 0.38% | 3,774,718 | |
| 443,042 | Institution | 0.38% | 3,774,718 |
FAQ
Who Owns Arcutis Biotherapeutics (ARQT)?
According to the latest TipRanks data, approximately 0.99% of the company's stock is held by institutional investors, 7.98% is held by insiders, and 58.49% is held by retail investors.
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.99% of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors.
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.49% of Arcutis Biotherapeutics (ARQT) stock is held by retail investors.
Who owns the most shares of Arcutis Biotherapeutics (ARQT)?
Vanguard owns the most shares of Arcutis Biotherapeutics (ARQT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.